A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

Dodd, Seetal, Malhi, Gin S., Tiller, John, Schweitzer, Isaac, Hickie, Ian, Khoo, Jon Paul, Bassett, Darryl L., Lyndon, Bill, Mitchell, Philip B., Parker, Gordon, Fitzgerald, Paul B., Udina, Marc, Singh, Ajeet, Moylan, Steven, Giorlando, Francesco, Doughty, Carolyn, Davey, Christopher G., Theodoros, Michael and Berk, Michael 2011, A consensus statement for safety monitoring guidelines of treatments for major depressive disorder, Australian and New Zealand journal of psychiatry, vol. 45, no. 9, pp. 712-725, doi: 10.3109/00048674.2011.595686.

Attached Files
Name Description MIMEType Size Downloads

Title A consensus statement for safety monitoring guidelines of treatments for major depressive disorder
Author(s) Dodd, SeetalORCID iD for Dodd, Seetal orcid.org/0000-0002-7918-4636
Malhi, Gin S.
Tiller, John
Schweitzer, Isaac
Hickie, Ian
Khoo, Jon Paul
Bassett, Darryl L.
Lyndon, Bill
Mitchell, Philip B.
Parker, Gordon
Fitzgerald, Paul B.
Udina, Marc
Singh, Ajeet
Moylan, Steven
Giorlando, Francesco
Doughty, Carolyn
Davey, Christopher G.
Theodoros, Michael
Berk, MichaelORCID iD for Berk, Michael orcid.org/0000-0002-5554-6946
Journal name Australian and New Zealand journal of psychiatry
Volume number 45
Issue number 9
Start page 712
End page 725
Total pages 14
Publisher Sage Publications
Place of publication London, England
Publication date 2011-09
ISSN 0004-8674
Keyword(s) safety
depressive disorders
Summary Objective: This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring.
Method: Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content.
Results: Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment.
Conclusion: The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.
Language eng
DOI 10.3109/00048674.2011.595686
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970117 Expanding Knowledge in Psychology and Cognitive Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2011, Sage
Persistent URL http://hdl.handle.net/10536/DRO/DU:30045322

Document type: Journal Article
Collection: School of Medicine
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 19 times in TR Web of Science
Scopus Citation Count Cited 22 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 769 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Tue, 15 May 2012, 14:27:53 EST by Jane Moschetti

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.